BioSpace News Archive

Monteris Medical announced today that the application for two new Category Level I CPT® code(s) for laser interstitial thermal therapy (LITT) of intracranial lesion, with magnetic resonance (MR) imaging guidance has been accepted by the American Medical Association (AMA) CPT® (Current Procedure Terminology) Editorial Panel. This

- Balanced immune response with strong induction of binding, and neutralizing antibodies and first indications of T cell activation - Quality of immune response comparable to recovered COVID-19 patients, closely mimicking immune response after natural COVID-19 infection

Company’s high-resolution preimplantation genetic testing platform enables discovery of unexpected - and unintended - CRISPR changes to human embryonic DNA.

aNew Orders; Production and Employment Growing; Supplier Deliveries Slowing at Faster Rate; Backlog Growing; Raw Materials Inventories Growing; Customers’ Inventories Too Low; Prices Increasing; Exports and Imports Growing

SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to announce its financial results as at and for three and nine-months ended August 31, 2020.

PPD, Inc. (Nasdaq: PPD ), was named the Clinical Research Company of the Year for winning multiple awards at the PharmaTimes Clinical Researcher of the Year competitions. In addition to PPD winning the highest honor at the PharmaTimes International Clinical Researcher of the Year 2020 virtual awards ceremony, individual PPD clinical researchers won gold and bronze in both the Clinical Research Associate (CRA) and

Tempus, a leader in artificial intelligence (AI) and precision medicine, today announced a strategic collaboration with Janssen Research & Development, LLC (Janssen), in which Tempus will work closely with Janssen data scientists and oncologists focused on oncology clinical development programs. The collaboration is part of a multi-year data agreement, which is facilitating predictive AI/machine learning projects, as well as

WCG today announced the appointment of two new independent members to its Board of Directors: Dr. Kavita Patel, a non-resident fellow with the Brookings Institution and a practicing physician, and Pascale Witz, a former senior pharmaceutical executive who has broad corporate board experience.

On September 30, 2020, the U.S. Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (DHHS) awarded IHRC, Inc. a 5-year, indefinite delivery/indefinite quantity contract, with a ceiling value of $49.5 million to provide support to the Office of Laboratory Safety (OLS).

Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, announced the appointment of Tom Pamukcoglu as Vice President – Global Head of Quality.